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Abstract
Background—Platelets are central to the process of haemostasis, rapidly aggregating at sites of 
blood vessel injury and acting as coagulation nidus sites. Upon interaction with sub-endothelial 
matrix platelets are transformed into balloon-like structures as part of the haemostatic response. 
It remains unclear, however, how and why platelets generate these structures. We set out to 
determine the physiological relevance and cellular and molecular mechanisms underlying 
platelet membrane ballooning.
Methods and Results—Using 4D live-cell imaging and electron microscopy, we show that 
human platelets adherent to collagen are transformed into phosphatidylserine-exposing balloon-
like structures with expansive macro/micro-vesiculate contact surfaces, by a process which we 
termed procoagulant-spreading. We reveal that ballooning is mechanistically and structurally 
distinct from membrane blebbing and involves disruption to the platelet microtubule 
cytoskeleton and inflation through fluid entry. Unlike blebbing, procoagulant ballooning is 
irreversible and a consequence of Na+, Cl- and water entry. Furthermore, membrane ballooning 
correlated with micro-particle generation. Inhibition of Na+, Cl- or water entry impaired 
ballooning, procoagulant-spreading, micro-particle generation and also diminished local 
thrombin generation. Human Scott syndrome platelets, which lack expression of Ano-6, also 
showed a marked reduction in membrane ballooning, consistent with a role for chloride entry in 
the process. Finally, blockade of water entry by acetazolamide attenuated ballooning in vitro, and 
markedly suppressed thrombus formation in vivo in a mouse model of thrombosis. 
Conclusions—Ballooning and procoagulant-spreading of platelets are driven by fluid entry into 
the cells, and are important for amplification of localised coagulation in thrombosis.   
Key words: cell physiology; hemostasis; coagulation; platelet; collagen; membrane ballooning; 
procoagulant-spreading; microparticles; fluorescent imaging; high-resolution microscopy 
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Introduction 
Platelets play complex roles in haemostasis and arterial thrombosis, rapidly adhering to sub-
endothelial structures and to each other to generate a platelet aggregate which is stabilised by the 
local production of thrombin and subsequently fibrin1.  Critical to this response is the surface 
exposure of aminophospholipids, particularly phosphatidylserine (PS), which promotes assembly 
of the tenase and prothrombinase complexes on the platelet surface.  This platelet-dependent 
procoagulant activity therefore depends upon two major factors: (i) the degree of PS exposure 
and (ii) the surface area of membrane with exposed PS.   
It is currently thought that a sustained rise in cytosolic Ca2+ is required for exposure of PS 
on the extracellular leaflet of the plasma membrane, through activation of a non-specific 
phospholipid scramblase and inhibition of a PS translocase or flippase. Anoctamin-6 (gene 
ANO6 or TMEM16F) is identified as a key regulator of calcium-dependent PS exposure2, and 
loss-of-function mutations in anoctamin-6 have been shown in two Scott syndrome patients3, 4, 
who have aberrant calcium-dependent scramblase activity5. However the precise role played by 
anoctamin-6 is still unclear. It is possible that, like other members of the anoctamin family, it 
forms Ca2+-activated Cl- channels6. Although much effort has gone into determining the 
molecular mechanisms regulating surface PS exposure, relatively little is known about the 
mechanisms by which platelet membrane surface area may be maximised. Possibly, Cl- entry 
may also be required for a change in membrane surface area, and this would be another distinct 
functional role for Cl- entry in potentiating platelet procoagulant activity.   
Platelets have long been reported to transform in vivo to form balloons upon activation, 
and fibrin has been shown to fill the space between these balloon structures at wound sites7-9. 
Platelet membrane ballooning has also been observed in vitro in platelets adherent to 
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immobilised collagen10-12. However, it is not clear whether this striking morphological change is 
analogous to apoptotic blebbing in other cell types13-15. Attempts to assess ballooning in platelets 
have been limited by the methods of investigation, imaging resolution10 and the fragility of the 
balloon structure which often results in its loss or significant deformation11.  
Here we hypothesised that platelet ballooning was important to markedly increase the 
surface area of exposed membrane, and exposed PS, thereby enhancing the local procoagulant 
response10, 16, 17.  We used detailed dynamic imaging approaches to visualise thrombin generation 
on platelet membrane surfaces and to understand the mechanisms regulating ballooning.  This 
study revealed that the key mechanism involves fluid entry, accompanied by the genesis of a 
novel spread membrane structure in a process we have termed ‘procoagulant-spreading’. Unlike 
conventional lamellipodial spreading, this form of spreading yields procoagulant surfaces, and 
rapidly breaks up by multiple coalescences to form numerous procoagulant microvesicles.  
Ballooning and procoagulant-spreading are therefore linked processes which are likely to 
contribute to hemostatic responses in vivo.   
Methods
Written informed consent was obtained in accordance with the Declaration of Helsinki.   
Human blood was obtained from healthy drug-free volunteers under Local Research Ethics 
approval (E5736). The UK Scott patient blood was obtained with NHS Research Ethics Committee 
approval, and has been described.  This Scott patient is a compound TMEM16F heterozygote, 
IVS6 + 1G?A, resulting in exon 6 skipping. Another mutation in this patient, (c.1219insT) causes 
premature translation termination and defective expression of TMEM16F4, 18.  
Materials
Details of materials used are given in Supplementary files.   
 at University of Bristol Library on September 2, 2015http://circ.ahajournals.org/Downloaded from 
DOI: 10.1161/CIRCULATIONAHA.114.015036 
5 
Platelet-rich plasma preparation 
Blood drawn from healthy human volunteers was anticoagulated with 0.4% trisodium citrate and 
acidified with 16% acid citrate dextrose (85 mmol/L trisodium citrate, 71 mmol/L citric acid, 111 
mmol/L glucose). Platelet-rich plasma (PRP) was obtained by centrifugation at 180 g for 17 min.  
Washed human platelet preparation 
PRP was centrifuged at 650 g for 10 min in the presence of 10 ?mol/L indomethacin and 0.02 
U/mL apyrase, and resuspended in HEPES-Tyrode’s buffer modified with 0.1% (w/v) glucose, 
10 ?mol/L indomethacin, and 0.02 U/mL apyrase. Sodium and chloride free HEPES-Tyrode’s 
buffers were prepared by replacing Na+ and Cl- with equimolar N-methyl-D glucamine and 
gluconate, respectively.  
Live cell confocal microscopy 
Washed human platelets were pre-incubated (10 minutes) with calcium dye Fluo-4 AM and 
Alexa Fluor 568 annexin-V conjugate (1%V/V). Hyperosmolar Tyrodes’ was prepared by adding 
40 mmol/L sucrose to HEPES-Tyrode’s buffer. MatTek dishes were pre-coated with collagen 
(20 μg/mL) and aliquots of platelet suspensions were added (2x107 cells/mL), supplemented with 
1 mmol/L CaCl2.  Changes in relative fluorescence intensity (F/F0) over time were monitored. 
Details of confocal microscopy are given in Supplementary files.   
Measurement of platelet thrombin generation
PRP was incubated with fluorogenic thrombin substrate, Z-GGR-AMC (450 μmol/L). PRP was 
re-calcified and thrombin generation initiated with 5 pmol/L tissue factor. Thrombin substrate 
was measured on platelet membrane surfaces and traces for single platelets and platelet 
aggregates were converted into first-derivative curves.  
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Image deconvolution and analysis 
Raw intensities from time-series (single plane over time) images were quantified after regions of 
interest were chosen and images corrected for background noise. For each platelet analysed, 
relative fluorescence (F/F0) is reported; where F0 designates the background-subtracted 
fluorescence level before platelet activation. Deconvolution of Z-stack images was based on 
calculated point spread functions; 3D & 4D reconstruction, movie rendering and co-localisation 
analysis were performed using Volocity imaging software (Perkin-Elmer, UK).   
In vitro and in vivo thrombosis assays
Details of in vitro and in vivo thrombosis assays are given in Supplementary files.   
Statistical analysis 
Data were analyzed using GraphPad Prism 6 (San Diego, CA) and presented as interleaved box 
plots with whiskers showing min to max values and interquartile ranges. We determined 
statistical significance by the Friedman test, followed by Dunn’s multiple comparison test or by 
Wilcoxon Signed Rank Test.   p<0.05 (*) or p<0.01 (**) was considered significant. 
Results 
Spatiotemporal dynamics of platelet membrane ballooning and phosphatidylserine 
exposure
Upon interaction with sub-endothelial matrix platelets are transformed into balloon-like structures 
as part of the haemostatic response7-10. To obtain more temporal and dynamic insight into platelet 
ballooning, we used phase-contrast and confocal live cell imaging microscopy techniques to study 
platelet adhesion and ballooning on a collagen-coated surface. In the early phases of contact with 
collagen, platelets formed small, retractable membrane blebs (Figure 1A, image 2-7, blue arrows). 
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However, in many platelets, one of these blebs can swell to become a balloon (Figure 1A, image 
10, yellow arrow), which ranged between 1 - 6 μm in diameter and typically did not retract (Figure 
1A, Movie S1). We identified three distinct phases leading to balloon formation, which we termed 
phases Ph1, Ph2 and Ph3 (Figure 1B). Ph1 was characterised by blebbing (membrane protrusion ? 1 
μm) (Figure 1A and B, images 1-5). During Ph2, the membrane of non-retracted blebs rapidly 
expanded (images 6-8) and in Ph3, the expansion plateaued (images 9-10). Initiation of ballooning 
was typically by 5 min after adhesion of the platelet to collagen fibre, and progressed rapidly to 
phase 3 by a further 5 min.  Importantly, we observed platelet ballooning in vivo, in a mouse 
thrombus formation model (Figure S1A), consistent with previous observations7-9. Ballooning also 
occurred in human thrombi, as shown in in vitro flow studies (Figure S1B, C).  Interestingly there 
was no ballooning in platelets adherent to von Willebrand factor in the presence of botrocetin, 
suggesting agonist specificity of the response.   
A 3D recontruction showed that the platelet body and the balloon membrane bound 
labelled annexin-V, demonstrating PS exposure and generation of a procoagulant surface5, 19-21 
(Figure 1C, Movie S2). Annexin-V binding was characterised by two stages: Initially, a low 
level (F/F0 = 1.3-1.5) of annexin-V accumulated on the membrane of the platelet body alone 
(Figure 1D, images 1-5), followed by annexin-V binding to the balloon as well (Figure 1D, 
images 7-10, Movie S3). Importantly, PS externalisation did not temporally correspond with 
membrane ballooning (Figure 1E&F), suggesting a distinction between the mechanisms 
underlying these two events. Furthermore, integrin ?IIb?3 was activated at an early time point 
prior to ballooning, but was sustained and localised just to the platelet body (Figure 1G, H).  
Thrombin is generated on the ballooned surface of human platelets adherent to collagen  
To demonstrate that ballooned platelets support a procoagulant response, we visualised the 
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formation of thrombin using the fluorogenic thrombin substrate Z-Gly-Gly-Arg aminomethyl 
coumarin (ZGGR-AMC, Figure 2Ai, cyan blue). 3D reconstruction further confirmed that 
thrombin was generated all over the balloon and platelet body (Figure 2Aii). Figure 2Aiii shows 
that thrombin is generated within 300-450 sec after platelet adhesion to collagen. This strongly 
correlated with balloon formation and annexin-V binding by single platelets (compare with 
Figure 1B and E, F).  
Platelets from patients with Scott syndrome show significantly impaired PS exposure and 
procoagulant activity18. Here we show that platelets from the UK Scott syndrome patient have a 
marked defect in balloon formation compared to control platelets (Figure 2B, see arrows). 
Platelet ballooning may therefore be important for the procoagulant response, by increasing the 
available surface area for recruitment of the tenase and prothrombinase complexes (Figure S2).  
Ballooned and procoagulant-spread (BAPS) platelets 
Using 4D imaging, we observed four distinct platelet phenotypes adherent to collagen (Figure
3A): (1) conventionally spread non-ballooned platelets (CSNB, annexin-V-), (2) ballooned and 
procoagulant-spread platelets (BAPS, annexin-V+), (3) ballooned non-spread platelets (BNS, 
annexin-V+) and (4) non-ballooned and non-spread platelets (NBNS). The NBNS phenotype was 
typically annexin-V- but could be induced to expose PS with prolonged stimulation. 
Procoagulant-spreading, in BAPS platelets, was only clearly identifiable by visualising annexin-
V just above (between 0 and 0.75 ?m) the collagen-coated surface (Figure 3A&B, in red, Movie
S4).  The area covered by procoagulant-spread platelets is generally much greater than by 
conventionally spread platelets and can extend to around 20 ?m (Figure 3A).  BAPS platelets 
constitute a distinct subpopulation of adherent platelets, and this report is the first 
characterisation of these structures.
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Ballooning and procoagulant-spreading are synchronised events 
4D live-cell imaging showed balloon formation started within 4 min after platelet adhesion and 
reached a maximal diameter by 9-10 min, as visualised by annexin-V binding (Figure 4A&B). 
Procoagulant membrane spreading followed membrane ballooning after a 1-2 min delay (Figure
4A-Ci) and both were temporally correlated (Figure 4Ci, Movies S5&S6). Only a small 
proportion of platelets (approx. 10%) ballooned without procoagulant-spreading (BNS; Figure
4Cii), and we did not observe procoagulant-spreading without ballooning These data suggest that 
ballooning is likely to be required for procoagulant-spreading, but not vice versa. In this 
experiment, after adhesion of platelets to collagen for 1 hr, the mean relative proportions of 
platelets were CSNB (27.4%), BNS (10.4%), BAPS (50.0%), NBNS AnxV- (5.9%), and NBNS 
AnxV+ (6.3%) (Figure 4Cii).    
BAPS platelets showed a punctate or cobble-stone annexin-V staining pattern (Figure
4A&B). In addition, BAPS platelets released microvesicles in a time-dependent manner (Suppl.
Figure S3) and scanning electron microscopy showed the cobble-stone appearance to be 
microvesicles formed from BAPS platelets after 1 h adhesion (Figure 4D-F). This was clearly 
distinct from the CSNB platelet (Figure 4E). We therefore suggest that procoagulant-spreading 
forms the basis for microvesicle formation and release upon adhesion of platelets to surfaces.   
Inhibition of actomyosin promotes membrane ballooning whilst blocking procoagulant-
spreading
To determine the role of the actin cytoskeleton in ballooning and procoagulant-spreading, 
platelets were incubated with modulators of actin polymerisation or myosin motor activity. 
Figure 5A shows representative figures of annexin-V binding to platelets adhered to collagen in 
the presence of these inhibitors. Blebbistatin, which blocks myosin-II ATPase activity22, 
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significantly promoted the progression of platelets ballooning and increased balloon diameter at 
Ph3 (Figure 5Aii, Figure S3). Similar results were found with platelets pre-treated with 
cytochalasin-D or Y27632. However, whilst enhancing ballooning, blebbistatin, cytochalasin-D 
and Y27632 inhibited spreading, and therefore formation of the BAPS morphology, so that 
platelets were restricted to the BNS phenotype (Figure 5Aii). Platelets treated with 
jasplakinolide, to promote actin polymerisation23, did not show any membrane ballooning or 
spreading. The data indicate that actin polymerisation and myosin contraction negatively control 
membrane ballooning. Inhibition of procoagulant-spreading using cytochalasin D also resulted in 
diminished thrombin generation (Figure 5B).  
Probing live platelets with AlexaFluor-350 phalloidin showed staining in the spread 
membranes of BAPS platelets (Figure 5C), indicating that their membrane integrity was likely 
to be compromised and that the balloons were actin-rich (see also Movie S7). In contrast, CSNB 
platelets were phalloidin negative.   
Platelet ballooning involves microtubule disruption at the exit point of the protrusion
Transmission electron microscopy images of platelets in the expansion phase (Ph2) of ballooning 
revealed a neck structure that delineated the balloon from the main platelet body (Figure S4A; 
yellow arrows), beneath which lay a disrupted microtubule ring structure, shown in detail by 
TEM tomography (Figure S4Aiii, green arrows; Movie S8). Significantly, there was no 
microtubule architecture present in Ph3 balloons (Figure S4B). In the later phases of balloon 
formation, the integrity of the membrane becomes compromised, since it becomes leaky to two 
low molecular weight dyes, calcein and propidium iodide (data not shown).  
Platelet ballooning and procoagulant-spreading requires salt and water entry 
The rapid growth of the platelet balloon suggested that it may be driven by fluid entry.  Our data 
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showed a 1.6 ± 0.02 fold increase in [Cl-]cyt after 5 min contact with collagen (Figure 6A&B), 
which was absent in Cl- free medium (not shown). In similar experiments, we recorded transient 
Na+ entry during platelet adherence to collagen (Figure 6C&D), which was absent in Na+ free 
medium (not shown). The percentage of adhered platelets that ballooned (Figure 6E) and 
underwent procoagulant-spreading (BAPS, Figure 6F) was significantly attenuated in media 
lacking Cl- or Na+ ions.  Interestingly, the peak change and half-life of annexin-V binding were 
significantly reduced under these conditions (Figure S3). It is likely that Cl- entry was substantially 
mediated by calcium-activated chloride channels (CaCC) since the inhibitor of these channels, 
CaCCinh-A01, induced similar effects to removal of extracellular Cl- (Figure 6E and F).  
To assess whether water entry was required for ballooning, we increased extracellular 
osmolality, using sucrose, by 40 mmol/L, which significantly attenuated both ballooning (Figure
7A) and procoagulant spreading (BAPS, Figure 7B), but not blebbing (Figure 7A). 
Furthermore, mean balloon diameter was attenuated in the small proportion of platelets able to 
balloon (Figure S3A). Acetazolamide has been shown to block aquaporin water channels24, and 
it induced a characteristic retraction of the ballooning membrane (Figure 7A) and attenuated 
membrane accumulation of annexin-V (Movie S9). Importantly, there was also a marked 
reduction in formation of BAPS platelets (Figure 7B), suggesting a requirement for water entry 
in procoagulant-spreading.   
In addition, acetazolamide and hyperosmotic challenge significantly reduced PS exposure 
and thrombin generation on the platelet surface (Figures 7C&D, S3B and Movies S9, 10). The 
mean intensity of thrombin substrate per unit membrane area was similar in BAPS and BNS 
platelets (Figure 7E), suggesting that the greater thrombin generation seen in controls was due to 
increased membrane surface area provided by ballooning and procoagulant-spreading.  
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Blocking water entry and ballooning significantly reduces in vivo thrombus formation.  
Mice were treated by bolus intravenous administration of acetazolamide (7 mg/kg) and carotid 
artery damage was induced by application of FeCl3 (10% v/v).  Accumulation of platelets, 
labelled with DyLight 488-antiGp1b?, was visualised by video epifluorescence microscopy.  
Whereas control mice showed rapid and sustained accumulation of platelets in a growing and 
eventually occlusive thrombus, mice treated with acetazolamide were markedly spared from this 
event (Figure 8). Balloon-enhanced local generation of thrombin will therefore likely form a 
positive feedback system to further activate platelets and promote coagulation.   
 
Discussion
Platelets are the surveillance cells of the vascular system, detecting vessel damage events and 
acting as the early and rapid response system to address the damage they recognise. They rapidly 
adhere to sub-endothelial matrix collagen, recruit more platelets to form an aggregate and 
stabilise the structure by initiating blood coagulation. This procoagulant activity depends on the 
surface exposure of negatively charged aminophospholipids, particularly phosphatidylserine 
(PS), which binds the tenase and prothrombinase complexes. The dynamics of platelet membrane 
transformation therefore underpin the coagulant response. Previous studies have shown that 
platelets are able to undergo both membrane blebbing and ballooning upon activation7-11, and 
that platelet balloon formation is part of the normal hemostatic response.  In particular the studies 
of Wester et al.,7, 8 used a template bleeding technique to induce acute wounds to human skin, 
and excised the wounds at various time periods after wounding.  Using histological and electron 
microscopic approaches they showed the existence of platelet balloons within the structure of the 
associated thrombus.  Importantly they showed that fibrin was deposited in the margins between 
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platelet balloons, suggesting a functional link between balloon formation and coagulation in 
vivo. Consistent with this, we demonstrated that activated factor V and X are bound to ballooned 
platelet membranes (Fig. S2).  We have determined the molecular regulation of these events, and 
revealed in real time the formation of a novel ballooned and procoagulant-spread (BAPS) 
platelet phenotype in a process we termed procoagulant-spreading. The balloon and 
procoagulant-spread structures are functionally linked and both contribute to the local generation 
of thrombin. BAPS platelets break into a multitude of procoagulant microvesicles, and this 
process may form a major route for generation of platelet-derived microvesicles which contribute 
to local hemostasis but with potential for pathological roles in various cardiovascular diseases25.   
While previous studies had described platelet membrane ballooning in some detail7, 8, 10, 
11, 26, this is the first report of coordinated membrane ballooning and procoagulant-spreading. 
Platelets with characteristics similar to the ballooned platelets seen here have been reported, 
particularly COATED and SCIP platelets18, 26.  However, there are clear differences, since 
platelets in this study showed sustained integrin ?IIb?3 activation (Figures 1G,H & S2) and 
transient increase in cytosolic calcium (data not shown).  Furthermore, data in Figure S2 and 
S4b show that the balloon retains some of the molecular and subcellular components of the 
platelet from which it was derived, including various surface receptor markers and mitochondria.  
The timing and localisation of PS exposure in platelets indicates that it does not appear 
until ballooning is well under way, suggesting that PS exposure is not a requirement for 
ballooning. Rather, platelet balloons result from physical disruption to the circumferential 
microtubule, accompanied by an increase in internal hydrostatic pressure provided by a 
coordinated Na+, Cl- and water entry mechanism, which inflates the balloon. By contrast, 
membrane blebbing analogous to that seen in cancerous cells is reversible and occurs 
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independent of fluid entry mechanisms27. It is possible that Na+ may enter through non-selective 
cation channels, such as TRPC628,  or by Na+/Ca2+ exchange. For Cl-, anoctamin (TMEM16) 
genes are key components of calcium-activated chloride channels, (CaCC)29-31. Anoctamin-6 is a 
CaCC6, 32 which functionally couples to TRPC channels33. Salt may therefore enter through 
regulated pathways, providing an osmotic drive for water entry and ballooning. The role of 
calcium in these events is pivotal since blockade of calcium entry or release from intracellular 
stores abolished ballooning and procoagulant-spreading, but not lamellipodial spreading (data 
not shown). A rise in cytosolic free Ca2+ may therefore trigger CaCC opening6 and allow 
chloride entry34.  Interestingly, the rise in cytosolic Na+ and Cl- ions concentrations are 
predominantly in the platelet cell body, rather than the balloon (Figure 6).  A possible 
explanation is that the major volume change occurs in the balloon, and not in the cell body. 
Likely, all increases in ion concentration in the balloon are continuously being diluted through 
entry of water. Related to this, we have never observed balloons to continue to grow or to burst, 
but always observe them reaching a plateau size.  We suggest that this is likely to be a product of 
this transient increase in ion permeability leading to a self-limiting water entry, constraining the 
balloon to a steady-state sustained volume.   
Scott syndrome is extremely rare and patients show a bleeding disorder associated with 
defective expression of TMEM16F and a resultant defect in microvesicle formation and exposure 
of PS5, 35. Our observations show that platelet ballooning is also markedly impaired in this 
syndrome (Figure 1C). It is possible that TMEM16F provides the critical mechanism driving 
ballooning, through regulated ion influx followed by water, and that the membrane stretching 
lowers the activation energy required for scrambling of membrane phospholipids and movement 
of inner leaflet PS to the outer leaflet.  
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Importantly, this study has revealed a novel phenotype which we have termed ballooned 
and procoagulant-spread (BAPS) platelets.  These structures break up to form procoagulant 
microvesicles and thereby increase the PS-exposing membrane surface area for procoagulant 
activity. That it had been previously missed in the literature was likely the result of the extremely 
thin and particulate nature of the spread membrane, which is only visible when platelets are 
stained with labelled annexin-V, under physiological concentrations of extracellular calcium and 
monitored over varying z-heights.  There was a direct link between ballooning and procoagulant-
spreading because inhibition of ballooning by CaCCinh-A01 (Figure 6E) or jasplakinolide or 
acetazolamide (Figures 5 & 7) also blocked procoagulant-spreading and microparticle 
generation (Figure S3). Agents that inhibit procoagulant-spreading independent of ballooning, 
such as blebbistatin, cytochalasin-D or Y27632, also largely inhibited microparticle formation 
(Figure S3).  It is therefore likely that all these events are functionally linked, and sequential, 
from ballooning to procoagulant-spreading to microparticle formation (Movies S5&S6).  It is 
interesting to note that endothelial PS exposure has recently been shown to play a major role in 
thrombin generation36.  However, it is possible that procoagulant-spreading may also allow 
platelets to contribute to coagulation over a much wider surface area than just the platelet ‘cell 
body’, which may explain any apparent discrepancy with Ivanciu et al. (2014).   
Our data would also suggest that as the hydrostatic pressure in the platelet cell body rises, 
it is able to sustain this increase in pressure due to the intact cytoskeleton of the cell.  However, 
once a weakness in the cytoskeleton develops, the membrane rapidly inflates to generate the 
balloon.  This leaves further questions, such as the molecular nature of the ion and water 
channels, and whether disruption of the cytoskeleton is a tightly coordinated event.  The fact 
however that acetazolamide is able to markedly diminish in vitro ballooning, and also act to 
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potently inhibit thrombus formation in vivo, indicates the importance of this event, and suggests 
potentially novel ways to control thrombus formation pharmacologically.   
In conclusion, this study has uncovered the molecular mechanisms that control dramatic 
platelet membrane ballooning and revealed a novel procoagulant-spread membrane structure, 
upon platelet activation by collagen. The events are mechanistically coupled and are likely to 
amplify the procoagulant responses at wound sites.  They also suggest a route by which platelets 
generate microparticles upon contact with collagen.  The mechanism of membrane ballooning 
shown here, which involves salt and water entry into the cells, may lead to new therapeutic 
directions for the control of thrombus formation in vivo.   
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Figure Legends: 
Figure 1. Spatiotemporal dynamics of human platelets undergoing ballooning and a 
procoagulant response upon adhesion to collagen. (A) & (B) Platelets were allowed to adhere to 
a collagen-coated surface and imaged by phase contrast video microscopy.  Images show the 
time course of interaction of a single platelet, with frame numbers in (A) corresponding to the 
time points shown in (B).  Three distinct phases of ballooning are shown as Ph1, Ph2 and Ph3. See 
also Movie S1.  (C) Rotated views of a 3D reconstruction of Alexa568-Annexin-V (AnxV; red) 
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stained ballooned platelet in Ph3.  See also Movie S2.  (D-F) Time course of a platelet 
undergoing ballooning upon adhesion to a collagen-coated surface.  Alexa568-AnxV-stained 
fluorescence images in (upper panel D, see also Movie S3) are superimposed upon phase 
contrast images (lower panel D).  Image frame numbers correspond to time points indicated in 
(E) & (F).  (E) displays the time course of AnxV staining in the platelet cell body and balloon, 
and the early time course after adhesion to collagen is indicated in the inset (F).  (G) Extended 
focus image showing Oregon green-488 human fibrinogen staining for activated integrin ?IIb?3 
(green) and Alexa568-AnxV (red).  The time course for fibrinogen (green) and AnxV (red) 
binding is shown in (H).  Scale bars: (A, C, D, G) 2μm, (B, E & F) 5 min.  Data are 
representative of 257 platelets from 9 donors.   
Figure 2. Thrombin is generated on the ballooned surface of human platelets adherent to collagen: 
Scott patient platelets show aberrant membrane ballooning. (A) Platelets in platelet-rich plasma 
were allowed to settle onto a collagen-coated surface, and thrombin activity was visualized in real-
time, by means of a fluorogenic thrombin substrate, Z-GGR-AMC.  A(i) Z-section of confocal 
image at 15 min shows the fluorogenic thrombin substrate on the membranes of ballooned 
platelets. A(ii) 3D reconstruction of platelets in A(i).  A(iii) shows the first derivative of the time 
course of thrombin generation in a representative single platelet after adhesion to the collagen-
coated surface. Scale bars in (i) and (ii) are 3 μm. . (B) Blood from healthy control (i) or a patient 
with Scott syndrome (ii) was flowed over a collagen-coated surface at 1000 s-1 for 4 min.  
Accumulated thrombi were stained with FITC-?CD62P mAb to detect P-selectin. Arrows indicate 
platelet balloons.  Scale bars in (i) and (ii) are 5 μm.  Data are representative of platelets from at 
least 3 donors (healthy) except Scott patient data in B(ii) where n=1.  
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Figure 3. A distinct subpopulation of ballooning platelets undergo extensive procoagulant-
spreading. Platelets were allowed to adhere to a collagen-coated surface for 1 hour and imaged 
by phase contrast and fluorescence video microscopy. (A) shows an overlay of phase contrast 
with Alexa568-Annexin-V (AnxV; red) and Fluo-4 (green).  Four phenotypes were observed, as 
indicated: non-ballooned non-spread platelets (NBNS), ballooned non-spread platelet (BNS), 
conventional spread non-ballooned platelet (CSNB) and ballooned and procoagulant-spread 
platelet (BAPS). (B) Z sections of the image shown in (A) at the indicated distance above the 
coated surface.  Shown are phase-contrast (i), Alexa568-AnxV (red, ii), Alexa568-AnxV (red) 
superimposed on Fluo-4 (green, iii), and combined overlay (iv). Scale bar: 10 μm. Data are 
representative of platelets from 9 human donors. See also associated Movie S4.   
 
Figure 4. Membrane ballooning and procoagulant-spreading are coordinated events. (A-C) 
Platelets were allowed to adhere to a collagen-coated surface and imaged by 4D fluorescence 
microscopy.  A time series of 3D reconstructions of a ballooned and procoagulant-spread 
(BAPS) platelet is shown in the X-Y axis (A, and see Movie S5) and X-Y-Z axis (B, and see 
Movie S6). Images are superimposed Alexa568-Annexin-V (AnxV; red) and DiOC6 (green). 
Spread membrane and balloon diameter of this platelet are shown in C(i), while C(ii) indicates 
the percentage of adherent platelets showing different phenotypes after 1 hr on collagen, 
abbreviated as per legend for Fig. 3. Data show min to max values, median and interquartile 
ranges. (D-F) Scanning electron microscopy images of platelets adherent to collagen show 
BAPS and conventional spread non-ballooned (CSNB) phenotypes as indicated (F is a zoomed-
in view of inset in E). Scale bar: 12 μm (A, B), 3 μm (D-F). Data are representative of platelets 
from 9 human donors.  
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Figure 5. Inhibition of actomyosin contraction promotes membrane ballooning whilst blocking 
procoagulant-spreading. Platelets were pre-incubated with DMSO (0.1%; control), blebbistatin 
(BBS; 80 μmol/L), cytochalasin-D (Cyt-D; 5 μmol/L), Y27632 (10 μmol/L) or jasplakinolide 
(Jaspl; 5 μmol/L) and allowed for 1 h to adhere to collagen coated surface. (A) (i) Top row 
shows extended focus fluorescence images of Alexa568-Annexin-V (AnxV; red), which were 
overlaid with phase-contrast images in bottom row. (ii) Interleaved box plots with whiskers 
showing min to max values, median and interquartile range. Graph indicates the percentage of 
adherent platelets observed showing different phenotypes. For abbreviations, see text for Fig. 3. 
Data analysis was by Friedman test, followed by Dunn’s multiple comparison test. P < 0.05 (*) 
or P < 0.01 (**) was considered significant.  (B) Mean intensity per platelet versus time plot, of 
the fluorogenic thrombin substrate, after adhesion to collagen.  Extended focus fluorescence 
images are control (i, ii) or cyto-D treated platelets (iii, iv) detecting thrombin substrate alone 
(cyan blue, i & iii) or overlaid with AnxV (ii & iv). (C) 3D reconstruction of adherent platelets 
stained with (i) fluo-4 (green), (ii) AnxV (red) and (iii) phalloidin (magenta), distinguishing 
CSNB and BAPS phenotypes as indicated. White and yellow bracket in C(ii) delineate the 
ballooned and procoagulant-spread segments of the BAPS platelet. C-iv shows an overlay of i - 
iii. Scale bar: 12 μm (A, B), 10 μm (C). Data are representative of platelets from 6 human 
donors. See also Movie S7 and Figure S3.  
  
Figure 6. Membrane ballooning and procoagulant-spreading is mediated by salt entry. (A-D) 
Platelets were pre-loaded with the chloride ion (Cl-) indicator MQAE (A,B) or the sodium ion 
(Na+) indicator CoroNa™ Green (C,D).  Cells were allowed to adhere to immobilised collagen 
and time-lapse fluorescence images captured. Images show the time course of interaction of a 
single platelet, with frame numbers in (A) & (C) corresponding to the time points shown in (B) 
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& (D) respectively.  Images in (A) show MQAE alone (Cyan blue, i), overlaid onto phase-
contrast image (ii) or on to Alexa568-Annexin-V (AnxV; red, iii). (B) shows fluorescence 
quantification (F/F0) for MQAE and Alexa568-AnxV, and mean balloon diameter. MQAE 
detects chloride ion entry by collisional quenching, thus decreases in F/F0 against time represent 
increases in [Cl-]i. Images in (C) show CoroNa™ Green alone (green, i) or overlaid on to phase-
contrast image (ii). (D) shows fluorescence quantification (F/F0) for CoroNa™Green and mean 
balloon diameter. (E&F) Platelets were pre-treated with DMSO (0.1%; control) or CaCCinh-
A01 (40 μmol/L) or resuspended in Cl--free or Na+-free media, and added to collagen-coated 
surfaces. The percentage of maximally adherent platelets undergoing membrane blebbing or 
ballooning over time is shown in (E).  Corresponding images are shown in the lower panels 
where AnxV (red) images are superimposed onto phase-contrast images. (F) shows phenotypes 
(abbreviated as per Fig. 3) of platelet adherent to collagen at 1 h time point; in interleaved box 
plots with whiskers showing min to max values, median and interquartile range. Data analysis 
was by Friedman test, followed by Dunn’s multiple comparison test. P < 0.05 (*) or P < 0.01 
(**) was considered significant. Scale bars: 3 μm (A, C), 10 μm (E). Time scale (B, D, E): 15 
min. Data are representative of platelets from 7 human donors.  
 
Figure 7. Water entry drives platelet membrane ballooning and procoagulant-spreading. (A) 
Platelets were untreated (control), resuspended in hyperosmolar solution (+40 mOsmol) or pre-
incubated with acetazolamide (40 μmol/L) and allowed 1 h, to settle onto collagen-coated 
surface. Graphs show the percentage of maximally adherent platelets undergoing membrane 
blebbing or ballooning over time.  Lower panels show representative images of Alexa568-
Annexin-V (AnxV) stained platelets (red) superimposed on corresponding phase-contrast 
images. (B) Bar chart shows the percentage of adherent platelets observed showing different 
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phenotypes, abbreviated as per Fig. 3; in interleaved box plots with whiskers showing min to 
max values, median and interquartile range. Data analysis was by Friedman test, followed by 
Dunn’s multiple comparison test. P < 0.05 (*) or P < 0.01 (**) was considered significant. (C)
extended focus fluorescence images showing fluorogenic thrombin substrate (cyan) (i: control, 
iii: acetazolamide) alone and superimposed onto AnxV stained platelets (red) (ii: control, iv: 
acetazolamide). (D) Fluoresence intensity versus time plot for fluorogenic thrombin substrate. 
(E) Specific fluorescence intensity of the thrombogenic substrate relative to platelet surface area 
of control and acetazolamide-treated platelets. Scale bar: 15 min (A, graphs), 10 μm (A lower 
panels, C). Data are representative of platelets from 6 human donors. See also Movie S9 and S10 
for videos of acetazolamide-treated and hyperosmolar-treated platelets undergoing reversible 
ballooning.    
  
Figure 8. Acetazolamide suppresses thrombus formation in vivo. Mice were administered
acetazolamide (7mg/kg) or vehicle by single bolus IV injection, followed immediately by 
DyLight 488-conjugated anti-GPIb? antibody to label platelets.  Carotid artery damage was 
achieved by treatment with FeCl3 as described in supplementary material. Fluorescently labelled 
platelets adhering at the site of injury could then be imaged continuously by intravital 
fluorescence microscopy.  Images at frames indicated in (A) correspond to time points indicated 
in (B (i)), which shows median fluorescence intensity, quantified using ImageJ. Analysis of area 
under the curve for media fluorescence is shown in B (ii) as interleaved box plots with whiskers 
showing min to max values, median and interquartile range. Data analysis was by Wilcoxon 
Signed Rank Test, P < 0.05 (*) was considered significant. Scale bar: 500 μM (A), 5 min (B). 
Data are from 8 mice.   
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SUPPLEMENTAL MATERIAL 
 
 
 
SUPPLEMENTARY METHODS 
Materials 
Fibrillar collagen (Horm suspension) was from Nycomed (Munich, Germany). Alexa Fluor® 
568 Conjugated Annexin V (annexin-V; anxV), Fluo-4 AM, propidium iodide, chloride ion 
indicator N-(Ethoxycarbonylmethyl)-6-methoxyquinolinium bromide (MQAE), and 
CoroNa™ green sodium indicator were purchased from Life Technologies. Glass bottom 
35mm dishes (P35G-1.5-20-C) were obtained from MatTek Corporation (USA). Flow 
chambers (Vena8™ biochip) were from Cellix Ltd. BAPTA-AM, blebbistatin, jasplakinolide, 
cytochalasin-D, Y27632, xestospongin-C and CaCCinh-A01 were purchased from Tocris 
(Bristol, UK).  Acetazolamide was purchased from Sigma-Aldrich (Poole, UK) 
 
Live cell confocal imaging 
Confocal images were acquired using a Perkin Elmer Ultra-VIEW ERS 6FE confocal system 
(with Yokogawa CSU22 spinning disk) attached to a Leica DM I6000 inverted 
epifluorescence microscope. The system is equipped with Piezo drive, Hamamatsu C9100-50 
EM-CCD camera (14 bit, 8 micron pixels) and the following laser lines: 14 mW Ar laser 
(488, 514 nm lines), 7.5 mW Kr laser (568 nm), 7.5 mW violet (405 nm) diode laser, 7mW 
blue diode laser (440 nm) and 7.5 mW Red diode (640 nm). Images were captured with 
Volocity (Improvision) acquisition software using an oil immersion objective lens (100x). 
Acquisition setting was kept constant and pixel width at x1 binning was 0.069 µm; phase-
contrast imaging was integrated with fluorescence imaging using emission discrimination 
mode. In selected experiments, image acquisition was done in real-time over variable z-
heights. 
 
Electron microscopy of mouse carotid artery 
The carotid artery was carefully excised and added to 2.5% glutaraldehyde in 0.1 mol/L 
sodium cacodylate buffer for 1 h. The tissue was post-fixed with 1% osmium tetroxide in 
sodium cacodylate buffer for 1 h, stained with 3% uranyl acetate in deionised water for 30 
min and dehydrated through a graded series of ethanol (70%, 80%, 90%, 96%) followed by 
three washes in 100% ethanol. The ethanol was replaced with propylene oxide prior to 
incubation in a 1:1 mixture of propylene oxide and Epon for 24 h. The propylene oxide was 
left to evaporate for 3 h before the tissue was added to fresh Epon which was hardened for 72 
h at 60°C. The artery was sectioned at a thickness of 70 nm. 
 
Correlative light-electron microscopy of platelets 
Platelets were seeded into live cell imaging dishes (MatTek) with an etched grid pattern in 
the glass. Upon completion of fluorescence imaging, the location of the platelets of interest 
on the grid was noted. Platelets were fixed with 2.5% glutaraldehyde in 0.1mol/L sodium 
cacodylate buffer (pH7.4) for 30 minutes. Platelets were post-fixed with 1% osmium 
tetroxide in sodium cacodylate buffer for 30 minutes and stained with 3% uranyl acetate in 
deionised water for 30 minutes. Platelets were dehydrated through a graded series of ethanol 
(70%, 80%, 90%, 96%) followed by three washes in 100% ethanol. Platelets were then 
embedded in pure Epon for 2 hours before being replaced with fresh Epon and hardened for 
48 hours at 60°C. The etched coverslip was removed by first submerging in liquid nitrogen 
and then plunging into boiling water. This process was repeated until the coverslip could be 
lifted away from the resin. The resin was then trimmed down to the area of interest and 
sectioned at a thickness of 250 nm. Transmission electron microscopy (TEM) images were 
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acquired on an Eagle 4k x 4k CCD camera attached to an FEI Tecnai 12, 120kV BioTwin 
Spirit. 
 
Transmission EM Tomography 
Sections were exposed to fiducial markers (10 nm gold particles) on both sides. A dual axis 
tilt series was acquired using an FEI Tecnai 20, 200kV TEM using a minimum angular range 
between -60° and +60°, acquiring images at 1° increments. The two tilt series were combined 
using IMOD reconstruction software. 
 
In vitro thrombosis assay 
Flow chambers (Vena8™ biochip) were coated with 50 μg/mL fibrillar collagen for 2 h at 
4°C. Chambers were then blocked with 2% fatty acid-free BSA (Sigma Aldrich) overnight at 
4°C. Human blood was drawn from healthy volunteers, under local ethics committee 
agreement and after fully informed consent. Blood was taken into 4% citrate (1:10 v/v) and 
supplemented with 2 units/mL heparin (Sigma Aldrich) and 40 μmol/L PPACK 
(Calbiochem). Blood was labelled with 2 μmol/L DiOC6 (3,3′-dihexyloxacarbocyanine 
iodide) for 10 min in the dark. Immediately prior to being passed through the flow chamber, 
6.6 mmol/L CaCl2 and 6.6 mmol/L MgCl2 were added. Blood was passed through the flow 
chamber at a rate of 1000 s
-1
 for 5 min. The flow chamber was washed for 5 min with 
HEPES-Tyrode’s buffer (10 mmol/L HEPES pH 7.2, 145 mmol/L NaCl, 3 mmol/L KCl, 0.5 
mmol/L Na2HPO4, 1 mmol/L MgSO4) to remove excess red blood cells. The chamber was 
visualised by confocal microscopy.  
 
Ferric chloride carotid injury model in mouse 
In vivo thrombus formation assays were performed as described here. Mice were bred and 
experimental procedures performed under UK Home Office licence PPL30/2908, held by 
AWP.  Mice were anaesthetised with ketamine 100 mg/kg (Vetalar V, Pfizer) and 10 mg/kg 
xylazine (Rompun, Bayer). Acetazolamide or control vehicle was administered by 
intravenous bolus and platelets were labelled by intravenous administration of 100 mg/kg 
Dylight-488 conjugated anti-GPIbβ antibody, 10 min prior to induction of thrombosis. Right 
carotid arteries were exposed and 2x1 mm 15% ferric chloride-soaked filter paper was placed 
on the arterial adventitia for 3 min. Time-lapse microscopy of the injury site for 20 min was 
performed and images processed using ImageJ. Background fluorescence values measured 
upstream of the injury site were subtracted from thrombus-specific fluorescence and data 
expressed as integrated densities.   
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SUPPLEMENTARY FIGURES 
 
 
Figure S1:  In vivo and in vitro evidence for ballooning of human platelet membranes 
under flow; related to Figure 1.  (A) Electron microscopy of a 30 min biopsy of mouse 
carotid artery following ferric chloride injury (A-ii and A-iii are zoomed-in views of insets in 
A-i and A-ii), respectively, with arrows pointing to balloons. (B) Confocal Z-section of a 
thrombus formed after DIOC6-stained (in green) whole human blood was perfused through 
collagen-coated capillaries (B-ii and B-iii are zoomed-in views of rectangular and oval insets 
in B-i, respectively, highlighting ballooned platelets.(C) Extended focus images of thrombus 
following in vitro flow of whole blood over collagen, showing annexin-V-labelled PS (in 
magenta) (C-i), DIOC6-stained (in green) platelets (C-ii), a combined overlay (C-iii) with 
arrows showing ballooned platelets, and an overlay onto phase-contrast (C-iv). Scale bar: 50 
µm (A-i), 10 µm (A-ii, C), 2 µm (A-iii), 20 µm (B-i), 2 µm (B-ii, B-iii). 
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Figure S2: Ballooned human platelets’ membrane expressed coagulation markers.  
Platelets allowed to undergo adhesion and full membrane ballooning (phase 3) over collagen-
coated surfaces.  Cells were then stained for expression of surface markers with anti FVa, anti 
FXa, anti-CD41, anti-GP1b, anti-P-selectin and anti-PAR1 and counterstained with 
Alexa568-AnxV as indicated. Oregon green conjugated human fibrinogen was also used to 
stain platelets as indicated. Scale bar = 3µm. Data were obtained from platelets analysed from 
3 human donors. 
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Figure S3: Mean balloon diameter and procoagulant response of human platelet 
adherent to collagen; related to Figure 2. (A) Platelets, treated as indicated, were 
monitored as they adhere to collagen. Mean membrane balloon diameter was measured 
during the stable phase of balloon formation (Ph3). (B) Spatio-temporal dynamics of 
phosphatidylserine exposure associated with platelet ballooning as revealed by annexin-V 
binding to platelets (in orange) or membrane balloons (in magenta). Summary charts show 
the peak change in annexin-V accumulation (i) and time required for annexin-V intensity to 
decay to 50% peak values (ii). (C) Microparticles (200-900 nm) released were identified by 
image intensity and counted; data are expressed as the number of microparticles divided by 
the number of platelets in the field of view. Data (mean ± SEM) are representative of 
platelets from 6-9 human donors. 
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Figure S4: Platelet ballooning involves microtubule disruption at the exit point of the 
protrusion; related to Figure 5. (A) Transmission electron microscopy of a ballooning 
human platelet (A-ii and A-iii are zoomed-in views of A-i and A-ii, respectively). A 
tomogram video file of (A-iii) is provided as Supplementary Movie 8. Green arrows in A 
point to unwinding microtubules; white arrows point to collagen fibre, red arrows point to 
balloon membrane, and yellow arrows  point to a ‘neck-like’ structure in the ballooning 
region of the platelet. (B) Correlative light-electron microscopy of a ballooned platelet.  
Phase-contrast overlay with annexin-V (in red) (B-i) and transmission electron microscope 
image (B-ii) of a platelet at Ph3 (B-iii is zoomed-in view of B-ii). Yellow arrows point to 
cristae within mitochondria. Scale bar: 1 µm (A-i), 500 nm (A-ii,iii), 2 µm (B-i), 500 nm (B-
ii, iii). Data was obtained from platelets analysed from 4 human donors. 
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SUPPLEMENTARY MOVIES 
 
Movie S1 
Platelet membrane ballooning is a consequence of adhesion to collagen; related to 
Figure 2. Confocal phase contrast images of human platelet adhering to fibrillar collagen 
were captured at the rate of 1 frame per 4 seconds. Confocal images were acquired using a 
Perkin Elmer Ultra-VIEW ERS 6FE confocal. Movie was created at 24 frames per second 
using Volocity 6.3 software. 
 
Movie S2 
Membrane balloon increases platelet procoagulant surface; related to Figure 2.  Movie 
is a 3D visualisation of a ballooned human platelet, showing copious accumulation of 
annexin-V (in red) on both platelet body and inflated/ballooned membrane. Images were 
acquired by Perkin Elmer Ultra-VIEW ERS 6FE confocal system. Rotated 3D reconstruction 
of image sections was performed as described in methods using Volocity 6.3 software.  
 
Movie S3 
Spatio-temporal dynamics of the early procoagulant response associated with collagen 
induced human platelet ballooning; related to Figure 2.  Fluo-4 (in green) and annexin-V 
(in red) were used to monitor calcium mobilisation and membrane exposure of 
phosphatidylserine in real time, respectively. Images were captured as described in methods 
at a frame per 4 seconds, using a Perkin Elmer Ultra-VIEW ERS 6FE confocal system.  
Movie was created at 24 frames/second using Volocity 6.3 software.  
 
 
Movie S4 
Ballooned and procoagulant-spread (BAPS) platelets are a distinct subpopulation of 
human platelet on collagen sites; related to Figure 3.  Fluo-4 (green) and annexin-V (red) 
were used to label intracellular calcium and externalised phosphatidylserine. A z-axis view is 
shown as image acquisition mode is switched from phase contrast to fluorescence mode. 
Images were captured at a frame per 4 seconds, using a Perkin Elmer Ultra-VIEW ERS 6FE 
confocal system.  Video rendition was done using Volocity 6.3 software. 
 
Movie S5 
Ballooning and procoagulant-spreading visualised (X-Y) orientation; related to Figure 
4. A 4-dimensional (4-D: xyz-t) reconstruction of human platelets adherent on collagen 
shows real time membrane dynamics in the X-Y axis. Images were captured using a Perkin 
Elmer Ultra-VIEW ERS 6FE confocal system. Images are superimposed annexin-V (red) and 
DIOC6 (green) 3D re-constructions at selected time-points previously indicated. Movie was 
created using Volocity 6.3 software. 
 
Movie S6 
Ballooning and procoagulant-spreading visualised in (X-Y-Z) orientation; related to 
Figure 4.  A 4-dimensional (4-D: xyz-t) reconstruction of human platelets adherent on 
collagen showing real time membrane dynamics in the X-Y-Z axis. Images were captured 
using a Perkin Elmer Ultra-VIEW ERS 6FE confocal. Images are superimposed annexin-V 
(red) and DIOC6 (green) 3D re-constructions at selected time-points previously indicated. 
Movie was created using Volocity 6.3 software. 
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Movie S7 
Actin localisation in ballooned and procoagulant-spread platelets; related to Figure 5. 
Actin was visualised by Alexa Fluor® 350 Phalloidin staining (magenta), intracellular 
calcium by Fluo-4 (green) and phosphatidylserine exposure by annexin-V (red). Images were 
captured using a Perkin Elmer Ultra-VIEW ERS 6FE confocal system. Movie was created 
using Volocity 6.3 software. 
 
Movie S8 
Platelets’ microtubule bundles disruption is associated with membrane ballooning 
related to Figure 5. Transmission electron microscopy images were acquired on an Eagle 4k 
x 4k CCD camera attached to an FEI Tecnai 20, 200kV BioTwin Spirit. Movie is a 
reconstructed single-axis tomogram showing microtubule disruption during active platelet 
ballooning.  
 
Movie S9 
Characteristic membrane retraction of acetazolamide pre-treated human platelet on 
collagen; related to Figure 7.  Annexin-V (red) membrane binding was used to monitor 
procoagulant activity. Fluo-4 (green) was used to monitor cytosolic calcium. Time-lapse 
images were captured as described in methods at a frame per 4 second, using a Perkin Elmer 
Ultra-VIEW ERS 6FE confocal system. Movie was created at 24 frames/second using 
Volocity 6.3 software. 
 
Movie S10 
Membrane balloon collapse in human platelet on collagen, under hyperosmolar 
challenge; related to Figure 7.  Annexin-V (red) membrane binding was used to monitor 
procoagulant activity. Time-lapse images were captured at the rate of 1 frame per 4 seconds, 
using a Perkin Elmer Ultra-VIEW ERS 6FE confocal system. Movie was created at 24 
frames/second using Volocity 6.3 software. 
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